American Biotechnology firm, Moderna (NASDAQ: MRNA) shares closed more than 12% higher on Monday after the company said it believes its COVID-19 vaccine protects against new variants found in Britain and South Africa. The company will publish data from its tests against the South African and UK...
American Biotechnology firm, Moderna (NASDAQ: MRNA) shares closed in positive for the second consecutive day. The $MRNA stock closed more than 6% higher on Wednesday after the early data of its experimental COVID-19 vaccine showed comparable immune response between older and younger volunteers...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.